Docebo Inc. (DCBO) Q4 2022 Earnings Call Transcript

Docebo Inc. (NASDAQ:DCBO) This fall 2022 Earnings Convention Name March 9, 2023 8:00 AM ET

Firm Members

Mike McCarthy – Vice President of Investor Relations

Claudio Erba – Chief Government Officer

Alessio Artuffo – President and Chief Working Officer

Sukaran Mehta – Chief Monetary Officer

Convention Name Members

Robert Younger – Canaccord Genuity

Josh Baer – Morgan Stanley

Scott Fletcher – CIBC

Daniel Chan – TD

Martin Toner – ATB Capital Markets

Suthan Sukumar – Stifel

Christian Sgro – Eight Capital


Good morning, everybody and welcome to Docebo Inc. This fall 2022 Earnings Name. All contributors are at the moment in a listen-only mode. We are going to open the road for a question-and-answer session for analysts following the presentation. Directions can be supplied at the moment for analysis analysts to ask questions. We ask that analysts please restrict themselves to 2 questions and return to the queue for any follow-ups.

I would now like to show the decision over to Docebo’s, Vice President of Investor Relations, Mike McCarthy. Please go forward, Mike.

Mike McCarthy

Thanks, Operator. Earlier than we start, Docebo wish to remind listeners that sure info mentioned right this moment could also be forward-looking in nature. Such forward-looking info displays the corporate’s present views with respect to future occasions. Any such info is topic to dangers, uncertainties and assumptions that would trigger precise outcomes to vary materially from these projected within the forward-looking statements. For extra info on the dangers, uncertainties and assumptions regarding forward-looking statements, please consult with Docebo’s public filings which can be found on SEDAR and EDGAR.

Through the name, we are going to reference sure non-IFRS monetary measures. Though we consider these measures present helpful supplemental details about our monetary efficiency, they aren’t acknowledged measures and shouldn’t have standardized meanings below IFRS. Please see our MD&A for extra info relating to our non-IFRS monetary measures, together with reconciliations